MB Heat shock protein
JAR Code: 306282207
ActiveFinancial Reports
| 2023 | 2024 | 2025 | ||
|---|---|---|---|---|
| Revenue | — | — | 0 | |
| Profit Before Tax | 0 | 0 | 0 | |
| Net Profit | 0 | 0 | 0 | |
| Equity | 6 000 | 6 000 | 6 000 | |
| Liabilities | 0 | 0 | 0 | |
| Total Assets | 6 000 | 6 000 | 6 000 |
Financial Reports
2025
Balance Sheet
Total Assets6 000 €
Long-term Assets0 €
Short-term Assets6 000 €
Equity6 000 €
Liabilities0 €
Profit & Loss Statement
Revenue0 €
Profit Before Tax0 €
Net Profit0 €
2024
Balance Sheet
Total Assets6 000 €
Long-term Assets0 €
Short-term Assets6 000 €
Equity6 000 €
Liabilities0 €
Profit & Loss Statement
Revenue—
Profit Before Tax0 €
Net Profit0 €
2023(2023-04-12 – 2023-12-31)9 mėn.
Balance Sheet
Total Assets6 000 €
Long-term Assets0 €
Short-term Assets6 000 €
Equity6 000 €
Liabilities0 €
Profit & Loss Statement
Revenue—
Profit Before Tax0 €
Net Profit0 €
Source: Registrų centras